• News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in Granules India

Granules India Gets USFDA Nod For Its Generic Amphetamine Mixed Salts

Citing IQVIA Health data, the company said Amphetamine mixed salts 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg and 30mg immediate release tablets had US sales of approximately USD 335 million for the most recent twelve months ending in October 2021.

Read More

Granules Subsidiary Clears USFDA Pre Approval Audit

The FDA issued two minor observations during the audit, the Hyderabad-based drug firm said in a regulatory filing.

Read More

Granules India Concludes COVID-19 Vaccine Drive For All Its Employees In India

The company has also put in place a dedicated 24/7 emergency care helpline, virtual doctor consultations, COVID-care hospital rooms with oxygen support and quarantine centers across Hyderabad and Visakhapatnam, Granules India said.

Read More

Granules India To Exit From China Joint Venture

Granules said it has a supply agreement with the joint venture and Ibuprofen API supply will not be impacted as the existing agreement will continue.

Read More